Skip to main content

UCD research offers potential for new ways to fight MRSA superbug

UCD research offers potential for new ways to fight MRSA superbug

MRSA is an antibiotic resistant superbug that causes 120,000 deaths annually.

A research collaboration between scientists at University College Dublin (UCD) and the University of Sheffield has led to a massive discovery regarding the superbug MRSA, opening up potential new ways to control the infectious disease.

The methicillin resistant staphylococcus aureus (MRSA) superbug is notoriously resistant to antibiotic treatments and causes 120,000 deaths each year. The new findings, which were published in the journal Science, could allow scientists to make breakthroughs in controlling MRSA.

The study, which was funded by Wellcome and UKRI, shows that MRSA has a double defense mechanism against antibiotics. Not only has the superbug developed a new cell wall enzyme that allows it to survive exposure to antibiotics, it has also evolved an alternative division mechanism that allows it to replicate in the presence of antibiotics.

“This discovery is important because it helps us to understand how bacteria can survive antibiotic treatment,” explained Dr Rebecca Corrigan, who is an assistant professor at UCD’s School of Medicine and co-author of the study.

“It is only through understanding this that we can develop new ways to treat MRSA infections in our efforts to tackle the antimicrobial resistance crisis,” she said.

Prof Jamie Hobbs from the University of Sheffield’s School of Mathematical and Physical Sciences said this research serves as a “fantastic example” of how physics and biology can be brought together “to understand the pressing societal challenge of antimicrobial resistance”.

“Our research demonstrates the power of an interdisciplinary approach to address the basic mechanisms supporting the physics of life which are of such importance to healthcare.”

The next step for the research team is to determine how MRSA can grow and divide in the presence of antibiotics using the mechanism that has been discovered.

Antibiotic resistance is a major health concern worldwide, with overuse and incorrect use of antibiotics a leading cause of bug resistance. The EU has a target to reduce consumption of antibiotics by 20pc by 2030.

The Irish Times reported that antibiotic use in Ireland continued to rise last year despite this concern, though superbug infections have reduced. And earlier this year, researchers found a new species of bacteria resistance to antibiotics in University Hospital Limerick.

CiarĂ¡n Mather

This article originally appeared on www.siliconrepublic.com and can be found here

You Might Also Be Interested In

  • 3 minute read
  • Published 23/09/2025

G&F Precision Molding Launches Irish Operations

G&F Precision Molding is excited to announce its expansion into Ireland, opening a new engineering and sales facility in Mullingar

Read more
  • Published 22/09/2025

Sod turned on IDA Ireland’s new Advance Building Solution in Mullingar

MULLINGAR Construction is underway on IDA Ireland’s cutting-edge Advance Building Solution (ABS)

Read more
  • 3 minute read
  • Published 19/09/2025

Alexion, AstraZeneca Rare Disease welcomes Irish partners to global operations hub in Cork, expanding opportunities for local life sciences collaboration

Alexion, AstraZeneca Rare Disease today welcomed government officials, academic leaders, and industry partners to its hub in Cork, reinforcing the company's commitment to productive partnerships and collaborative relationships within Ireland's life sciences sector

Read more